Top Story

Zeiss appoints Jim Mazzo as global president of ophthalmology

Zeiss appoints Jim Mazzo as global president of ophthalmology
July 27, 2016

Carl Zeiss Meditec appointed James V. Mazzo as global president of ophthalmology, according to a company press release.

In this role, Mazzo will be responsible for leading the new strategic business unit of ophthalmology and the company’s U.S. sales and service center.

CommentaryFrom OSN APAO

Health care providers have duty to reduce impact of their work on environment

Ocular Surgery News APAO Edition, July 2016
Bhaskar Srinivasan, MD; Dennis S.C. Lam, MD, FRCOphth
Climate change is predicted to be one of the largest health threats of the 21st century. Human activities are increasing the release of greenhouse gases, leading to…
Cover StoryFrom OSN APAO

Hospital chain in India sets a model for low carbon footprint, environment-friendly cataract surgery

Ocular Surgery News APAO Edition, July 2016
Health care procedures are a large contributor to carbon emissions throughout the world. As awareness and concerns about the environmental issues related to global…

Sight Sciences receives IDE approval to initiate clinical trial of ab interno canaloplasty system vs. SLT

July 27, 2016
Sight Sciences received full investigational device exemption approval from the FDA to initiate a clinical trial comparing ab interno canaloplasty and selective laser…

TANZANITE study: No re-treatments required with triamcinolone acetonide formulation after 3 months

July 27, 2016
A majority of patients treated with a proprietary form of triamcinolone acetonide in combination with aflibercept required no additional treatments over 3 months…
More News Headlines »
Original Article

Comparison of Anterior Segment Parameters Obtained by Dual-Scheimpflug Analyzer Before and After Cycloplegia in Children

Journal of Pediatric Ophthalmology and Strabismus, July/August 2016, Volume 53 Issue 4
To assess the changes of anterior segment parameters with cycloplegia. A cross-sectional study of healthy pediatric…
More »

Central and Branch Retinal Vein Occlusion Clinical Trials: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Highlights from ASCRS

Highlights from ASCRS

Meeting News Coverage

VIDEO: Speaker talks use of spot vision screener on patients with developmental disability

July 18, 2016
More »